GOC Summary Statement on Current Status of Ovarian Cancer Screening with Ca125 and Transvaginal Ultrasound in Women Aged 55-74
Username:
Password:
Forgot your password  |  Become a member
  • About GOC
  • Meetings and Events
  • CME
  • Case Presentations
  • News
  • Membership
  • Patient Advocacy
  • Resources
GOC Banner
GOC Position Statement - Intraperitoneal Chemotherapy for Ovarian Cancer
GOC Position Statement - Prophylactic HPV Vaccines
GOC Position on NACI Statement on Human Papillomavirus Vaccine
GOC Position Statement Regarding Ovarian Cancer Screening
GOC Statement regarding CA125 Monitoring in the Management of Recurrent Ovarian Cancer
GOC Position Statement Regarding the Resignation of Three Gynecologic Oncologists in Newfoundland and Labrador
GOC Statement Regarding: Regarding: BC’s Gynecologists change surgical method to protect against
GOC Summary Statement on Current Status of Ovarian Cancer Screening with Ca125 and Transvaginal Ultrasound in Women Aged 55-74
GOC Position Statement of Cervical Cancer Vaccines
GOC Statement Regarding Salpintectomy and Ovarian Cancer Prevention
GOC Statement Regarding NACI Update on HPV Vaccines

GOC Summary Statement on Current Status of Ovarian Cancer Screening with Ca125 and Transvaginal Ultrasound in Women Aged 55-74




June 17, 2011: GOC Summary Statement on Current Status of Ovarian Cancer Screening with Ca125 and Transvaginal Ultrasound in Women Aged 55-74 (PDF document)

le 17 juin 2011 : Déclaration sommaire de la GOC au sujet de l'état actuel du dépistage du cancer de l'ovaire à l'aide de l'antigène ca125 et de l'échographie transvaginale chez les femmes âgées de 55 à 74 ans (document PDF)


A founding partner of CG²#
  • Sitemap
  • Contact Us
  • Privacy Policy
  • Home
Web Development by Atomic Motion